PYPavel A. Yastrebov

Pavel A. Yastrebov

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Pavel A. Yastrebov has a total of 12 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Diagnosing burn depth by assessing water balance indicators and ultrasound imaging

    by Igor’ V. Chmyrev, Boris A. Paramonov, Pavel A. Yastrebov

    BACKGROUND: In 2024, over 125,000 burn victims sought medical help in the Russian Federation. The overall mortality rate among adults averaged 6.8%. Diagnosing burn depth, which is crucial for selecting proper treatment tactics, is primarily based on clinical presentation and subjectively assessed diagnostic tests. This approach correctly determines burn degree in only 60%–70% of cases. Various instrumental techniques used to improve diagnostic accuracy have significant drawbacks. For instance, laser Doppler visualization has relatively low diagnostic value during the first 24 hours post-injury, requires a comparatively long procedure time, and demands that the patient remain completely still. The significance of thermography decreases with increased evaporation from the burn surface, presence of eschar, vasospasm, and other circumstances. Photoacoustic visualization, infrared and Raman spectroscopy, optical coherence tomography, and other methods all have their own limitations. The absence of a universal instrumental method for determining burn degree necessitates the search for new diagnostic approaches. AIM: This work aimed to evaluate the possibility of differentiating between deep and superficial burns during the early period after thermal injury based on skin hydration parameters and ultrasound data of burned skin. METHODS: The experiment was conducted on 16 white outbred rats. A burn was inflicted by firmly pressing the open part of a test tube with boiling water against the skin of an anesthetized rat for 15 seconds to produce a superficial burn and for 30 seconds for a deep burn. Before the burn and for 2 hours after the burn, the hydration level of the superficial skin layers and transepidermal water loss were determined by corneometry and tewametry, respectively. To determine the depth of skin necrosis after the burn, ultrasound diagnostics were performed. RESULTS: In superficial burns, corneometry values were significantly higher than in deep burns (p = 0.046), and the depth of necrosis measured by ultrasound was significantly smaller (p = 0.00019). Median transepidermal water loss values in superficial burns were greater than in deep burns, but not significantly. CONCLUSION: Ultrasound examination of the skin can provide high diagnostic accuracy in determining burn depth. Conducting new studies using corneometry and tewametry may be useful for correctly determining burn degree.

  • Open Access

    Pathogenetic approaches to enhancing local treatment strategies for skin burns

    by Igor’ V. Chmyrev, Boris A. Paramonov, Pavel A. Yastrebov, Levon K. Avetisyan

    This study examined the pathogenetic mechanisms of burn wound deepening and confirmed approaches for optimizing local burn treatment strategies. In Russia, approximately 300,000 burn cases are registered annually, the majority of which are superficial and partial-thickness burns. A well-studied occurrence in burn pathology is the progressive deepening of wounds over time. Fundamental principles explaining this phenomenon were established long ago. Some tissues undergo instantaneous necrosis due to thermal exposure (primary necrosis zone), whereas other tissues undergo progressive necrosis caused by a cascade of complex pathogenetic changes (secondary necrosis zone). Understanding the early pathogenetic mechanisms initiated in the early phase of thermal injury may contribute to the development of new therapeutic approaches. A comprehensive literature review was conducted using electronic databases (i.e., eLibrary, PubMed, Scopus, Google Scholar, ResearchGate, and ScienceDirect) to analyze Russian and international studies on burn necrosis progression. The primary contributors to secondary necrosis in skin burns (i.e., tissue hyperthermia, microcirculatory dysfunction, and inflammation) are associated with inflammatory cascade reactions involving multiple mechanisms, including reactive oxygen species-mediated cell damage, apoptosis initiation, neutrophil extracellular trap formation, autophagy, and other processes. Burn-induced cell death leads to the release of damage-associated molecular patterns, whereas skin barrier disruption facilitates the penetration of pathogen-associated molecular patterns into tissues, amplifying the inflammatory response. These processes may be prevented, which may help reduce the depth of the burn. Experimental and clinical studies on various pharmacological agents and drug formulations aimed at stopping necrosis progression indicate that erythropoietin derivatives, anti-cytokine agents and their combinations, complement activation inhibitors, antioxidants, mitophagy stimulators (e.g., PTEN-induced kinase 1 and ubiquitin ligase), and other active compounds reduce necrotic expansion. Furthermore, nanoemulsions and hydrogels developed using microfluidic technology, along with other modern drug formulations, potentially prevent progressive tissue necrosis and enhance the biological availability of active substances. Therefore, multi-targeted therapies that address all pathogenetic components of necrosis progression should be developed.

  • Open Access

    Clinical case of olokizumab treatment in a patient with diffuse systemic sclerosis

    by E. S. Kuvardin, D. Yu. Andreev, P. A. Yastrebov, V. Yu. Myachikova, D. V. Bukhanova, D. V. Karpova, K. N. Malikov, M. Yu. Samsonov, A. L. Maslyanskiy, В. Ю. Мячикова

    Treatment algorithms for systemic sclerosis have not been completely developed. Effectivity of medications are usually used in clinical practice has a low level of evidence. Therefore, it is necessary to find a new treatment approaches for this nosological form. In the paper described clinical case of olokizumab treatment in a patient with diffuse systemic sclerosis with interstitial lung disease, polyserositis, severe microcirculatory alterations.